Speedy recovery: Low-Dose sedative gets breast cancer patients home in under 2 hours
NCT ID NCT07180810
First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tested whether a low dose of the sedative dexmedetomidine could help women leave the hospital sooner after day-case breast cancer surgery. 82 women were randomly assigned to receive either the drug or a placebo during surgery. The main goal was to see how many could be discharged within 2 hours. The results could point to a simple way to speed up recovery and improve comfort after surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
dexmedetomidine
What this could lead to
If it works, this could help women recover faster and go home sooner after breast cancer surgery, reducing hospital stays.
What could go wrong
This is a small, completed trial with 82 participants. The drug may cause side effects like low heart rate or drowsiness, and results may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shaukat Khanum Memorial Cancer Hospital and Research Centre
Lahore, Pubjab, 54782, Pakistan